The fibrotic capsule in hepatocellular carcinoma is known to act as a barrier to the spread of cancer cells.31 Hence, the barrier function of encapsulated CRLM may be reducing the aggressiveness and metastatic growth, which would otherwise result due to the increased expression and activation of the HIF-1α pathway. Here, HIF1A is linked to hepatocellular carcinoma.